| JXHB2000018 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2020-08-28 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Quotient Sciences Philadelphia LLC;Eli Lilly & Company | In Review | 2020-08-26 | view |
| JXHB2000017 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2020-08-28 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Quotient Sciences Philadelphia LLC;Eli Lilly & Company | In Review | 2020-08-26 | view |
| JXHB2100003 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-01-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company;Lilly Del Caribe Inc | In Review | 2021-01-07 | view |
| JXHL2100092 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2100091 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2100090 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2000260 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2020-09-22 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-09-21 | view |
| JXHB2100004 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-01-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company;Lilly Del Caribe Inc | In Review | 2021-01-07 | view |
| JXHL2000259 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2020-09-22 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-09-21 | view |
| JXHL2100093 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2100113 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXHL2100114 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXHL2100115 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXSL2100045 | LY3471851注射液 | | Injection | Biological Products(1) | Import Drug Application | 2021-03-31 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-30 | view |
| CXSL2400415 | LY3540378注射液 | | Injection | Biological Products(1) | New Drug Application | 2024-06-27 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CXL20023024 | LY582563/MCC-478 | alamifovir | Active ingredient | Chemical Drugs(1) | New Drug Application | 2002-11-29 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2003-07-07 | view |
| CXL20023025 | LY582563/MCC-478片 | alamifovir | Tablet | Chemical Drugs(1) | New Drug Application | 2002-11-29 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2003-07-07 | view |
| CXL20023026 | LY582563/MCC-478片 | alamifovir | Tablet | Chemical Drugs(1) | New Drug Application | 2002-11-29 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Pending Approval | 2003-05-09 | view |
| JXSB2100016 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-02-27 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-02-26 | view |
| JXSB2100025 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
